CTi Biopharma Corp (NASDAQ:CTIC)

Delayed Data
As of Mar 19
 -0.05 / -1.25%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for CTi Biopharma Corp have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a +90.36% increase from the last price of 3.94.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in CTi Biopharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.03%
Growthannually 33.33%


Growthquarterly 8.23%
Growthannually -55.06%
Key to the earnings and sales forecast charts.